Daito Pharmaceutical: Announcements of individual stocks regarding strengthening capital business partnerships related to China business.
Daito Pharmaceutical: Announcements of individual stocks regarding the cancellation of their own shares.
Daito Pharmaceutical: Announcements of individual stocks regarding organizational changes.
Daito Pharmaceutical: Announcements of individual stocks regarding changes in the position of our representative director and the transfer of director positions.
Daito Pharmaceutical: Regarding the signing of the "Agreement for Building Partnership" between Dai Co., Ltd. and Nobel Pharma Co., Ltd.
Daito Pharmaceutical: Notice regarding changes in executive officers
Daito Pharmaceutical: Notice regarding the second phase construction of the 10th Pharmaceutical Building
Daito Pharmaceutical: Notice regarding completion of the General Research Center
Daito Pharmaceutical: Notice regarding completion of cancellation of treasury stock
Daito Pharmaceutical: Notice regarding the completion of the 10th Pharmaceutical Building
Daito Pharmaceutical: Notice Concerning Changes in Our Executive Officers and Changes in Representative Directors of Our Subsidiaries
Daito Pharmaceutical: Notice of New Release of Authorized Generic (AG) Product “Zinc Acetate Tablets “Nobel”
Daito Pharmaceutical: Articles of Incorporation 2023/09/01
Daito Pharmaceutical: Notice Concerning Obtaining Approval for Methotrexate Tablets from the U.S. Food and Drug Administration (FDA)
Daito Pharmaceutical: Notice regarding changes in directors and executive officers
Daito Pharmaceutical: Articles of association 2023-03-01
Daito Pharmaceutical: Notice on the transfer of Executive Director
Daito Pharmaceutical Co Ltd: Notice on the decision on Stock acquisition in the Stock reward system
Daito Pharmaceutical Co Ltd: Articles of association 2022-08-24
Daito Pharmaceutical Co Ltd: Notice of independent director
No Data